Prenatal vitamin K1 administration in epileptic women to prevent neonatal hemorrhage

Is it fffective?

Waralak Yamasmit, Surasith Chaithongwongwatthana, Jorge Tolosa

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

OBJECTIVE: To summarize current knowledge on whether prenatal prophylactic vitamin K1 administration to epileptic women receiving enzyme-inducing antiepileptic drugs (AEDs) to prevent neonatal hemorrhage is effective. STUDY DESIGN: A computerized MEDLINE search was conducted using the terms antiepileptic drug, hemorrhagic disease of the newborn, pregnancy and vitamin K since 1966 to July 2004, limited only to human studies. English-language publications were selected based on their relevance to the clinical effectiveness of administration of oral vitamin K to epileptic women exposed to enzyme-inducing AEDs for prevention of hemorrhagic disease of the newborn (HDN). RESULTS: No randomized, controlled trial testing prenatal vitamin K1 administration for reducing the incidence or severity of neonatal hemorrhage was identified. This review summarizes the data from published observational studies. CONCLUSION: There is inadequate evidence to recommend the routine administration of prenatal vitamin K to epileptic women exposed to enzyme-inducing AED therapy in order to prevent HDN.

Original languageEnglish (US)
Pages (from-to)463-466
Number of pages4
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume51
Issue number6
StatePublished - Jun 2006

Fingerprint

Vitamin K 1
Vitamin K Deficiency Bleeding
Anticonvulsants
Vitamin K
Hemorrhage
Enzymes
MEDLINE
Observational Studies
Oral Administration
Publications
Language
Randomized Controlled Trials
Drug Therapy
Pregnancy
Incidence

Keywords

  • Epilepsy
  • Hemorrhagic disease of newborn
  • Vitamin K1

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Prenatal vitamin K1 administration in epileptic women to prevent neonatal hemorrhage : Is it fffective? / Yamasmit, Waralak; Chaithongwongwatthana, Surasith; Tolosa, Jorge.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 51, No. 6, 06.2006, p. 463-466.

Research output: Contribution to journalArticle

@article{a61b88fabc7541deb768753f9768703c,
title = "Prenatal vitamin K1 administration in epileptic women to prevent neonatal hemorrhage: Is it fffective?",
abstract = "OBJECTIVE: To summarize current knowledge on whether prenatal prophylactic vitamin K1 administration to epileptic women receiving enzyme-inducing antiepileptic drugs (AEDs) to prevent neonatal hemorrhage is effective. STUDY DESIGN: A computerized MEDLINE search was conducted using the terms antiepileptic drug, hemorrhagic disease of the newborn, pregnancy and vitamin K since 1966 to July 2004, limited only to human studies. English-language publications were selected based on their relevance to the clinical effectiveness of administration of oral vitamin K to epileptic women exposed to enzyme-inducing AEDs for prevention of hemorrhagic disease of the newborn (HDN). RESULTS: No randomized, controlled trial testing prenatal vitamin K1 administration for reducing the incidence or severity of neonatal hemorrhage was identified. This review summarizes the data from published observational studies. CONCLUSION: There is inadequate evidence to recommend the routine administration of prenatal vitamin K to epileptic women exposed to enzyme-inducing AED therapy in order to prevent HDN.",
keywords = "Epilepsy, Hemorrhagic disease of newborn, Vitamin K1",
author = "Waralak Yamasmit and Surasith Chaithongwongwatthana and Jorge Tolosa",
year = "2006",
month = "6",
language = "English (US)",
volume = "51",
pages = "463--466",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "6",

}

TY - JOUR

T1 - Prenatal vitamin K1 administration in epileptic women to prevent neonatal hemorrhage

T2 - Is it fffective?

AU - Yamasmit, Waralak

AU - Chaithongwongwatthana, Surasith

AU - Tolosa, Jorge

PY - 2006/6

Y1 - 2006/6

N2 - OBJECTIVE: To summarize current knowledge on whether prenatal prophylactic vitamin K1 administration to epileptic women receiving enzyme-inducing antiepileptic drugs (AEDs) to prevent neonatal hemorrhage is effective. STUDY DESIGN: A computerized MEDLINE search was conducted using the terms antiepileptic drug, hemorrhagic disease of the newborn, pregnancy and vitamin K since 1966 to July 2004, limited only to human studies. English-language publications were selected based on their relevance to the clinical effectiveness of administration of oral vitamin K to epileptic women exposed to enzyme-inducing AEDs for prevention of hemorrhagic disease of the newborn (HDN). RESULTS: No randomized, controlled trial testing prenatal vitamin K1 administration for reducing the incidence or severity of neonatal hemorrhage was identified. This review summarizes the data from published observational studies. CONCLUSION: There is inadequate evidence to recommend the routine administration of prenatal vitamin K to epileptic women exposed to enzyme-inducing AED therapy in order to prevent HDN.

AB - OBJECTIVE: To summarize current knowledge on whether prenatal prophylactic vitamin K1 administration to epileptic women receiving enzyme-inducing antiepileptic drugs (AEDs) to prevent neonatal hemorrhage is effective. STUDY DESIGN: A computerized MEDLINE search was conducted using the terms antiepileptic drug, hemorrhagic disease of the newborn, pregnancy and vitamin K since 1966 to July 2004, limited only to human studies. English-language publications were selected based on their relevance to the clinical effectiveness of administration of oral vitamin K to epileptic women exposed to enzyme-inducing AEDs for prevention of hemorrhagic disease of the newborn (HDN). RESULTS: No randomized, controlled trial testing prenatal vitamin K1 administration for reducing the incidence or severity of neonatal hemorrhage was identified. This review summarizes the data from published observational studies. CONCLUSION: There is inadequate evidence to recommend the routine administration of prenatal vitamin K to epileptic women exposed to enzyme-inducing AED therapy in order to prevent HDN.

KW - Epilepsy

KW - Hemorrhagic disease of newborn

KW - Vitamin K1

UR - http://www.scopus.com/inward/record.url?scp=33745219477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745219477&partnerID=8YFLogxK

M3 - Article

VL - 51

SP - 463

EP - 466

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 6

ER -